Drew Hannaman has served as the Vice President of Research & Development at Ichor Medical Systems since 2000. In that role he has been responsible for the development of the company's electroporation based TriGrid Delivery System for DNA vaccine administration. The technology has been incorporated into more than 20 clinical stage products addressing a range of disease indications. He is a co-author of over 40 publications in the field of DNA based biologics. He holds a degree in Cybernetics from the University of California, Los Angeles and has over twenty years of experience in the development of drug delivery systems.